0 01/06/2024 31/05/2025 2025-05-31 false false false false false false true true false false true false false false false false false false No description of principal activities is disclosed 2024-06-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP NI679621 2024-06-01 2025-05-31 NI679621 2025-05-31 NI679621 2024-05-31 NI679621 2023-06-01 2024-05-31 NI679621 2024-05-31 NI679621 2023-05-31 NI679621 bus:RegisteredOffice 2024-06-01 2025-05-31 NI679621 bus:LeadAgentIfApplicable 2024-06-01 2025-05-31 NI679621 bus:Director1 2024-06-01 2025-05-31 NI679621 bus:Micro-entities 2024-06-01 2025-05-31 NI679621 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 NI679621 bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 NI679621 bus:EntityHasNeverTraded 2024-06-01 2025-05-31 NI679621 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 NI679621 bus:FullAccounts 2024-06-01 2025-05-31
Company registration number: NI679621
Glenbio Pharma UK Ltd
Unaudited filleted financial statements
31 May 2025
Glenbio Pharma UK Ltd
Contents
Directors and other information
Accountant's report
Statement of financial position
Glenbio Pharma UK Ltd
Directors and other information

| Directors | Mr John McIntosh
| Company number | NI679621
| Registered office | 10 Kilbegs Road
|  | Antrim
|  | BT41 4NN
| Business address | 10 Kilbegs Road
|  | Antrim
|  | BT41 4NN
| Accountant | Mark Kilgore & Co.
|  | 82 Castle Street
|  | Ballycastle
|  | Co. Antrim
|  | BT54 6AR

Glenbio Pharma UK Ltd
Report to the board of directors on the preparation of the
unaudited statutory financial statements of Glenbio Pharma UK Ltd
Year ended 31 May 2025
In order to assist you to fulfil your duties under the Companies Act 2006, I have prepared for your approval the financial statements of Glenbio Pharma UK Ltd for the year ended 31 May 2025 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given me.
As a practising member of Chartered Accountants Ireland , I am subject to its ethical and other professional requirements which are detailed at www.charteredaccountants.ie.
This report is made solely to the board of directors of Glenbio Pharma UK Ltd, as a body, in accordance with the terms of my engagement letter. My work has been undertaken solely to prepare for your approval the financial statements of Glenbio Pharma UK Ltd and state those matters that we have agreed to state to the board of directors of Glenbio Pharma UK Ltd as a body, in this report in accordance with the requirements of Chartered Accountants Ireland as detailed at www.charteredaccountants.ie. To the fullest extent permitted by law, I do not accept or assume responsibility to anyone other than Glenbio Pharma UK Ltd and its board of directors as a body for my work or for this report.
It is your duty to ensure that Glenbio Pharma UK Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Glenbio Pharma UK Ltd. You consider that Glenbio Pharma UK Ltd is exempt from the statutory audit requirement for the year.
I have not been instructed to carry out an audit or a review of the financial statements of Glenbio Pharma UK Ltd. For this reason, I have not verified the accuracy or completeness of the accounting records or information and explanations you have given to me and I do not, therefore, express any opinion on the statutory financial statements.
Mark Kilgore & Co.
Chartered Accountants
82 Castle Street
Ballycastle
Co. Antrim
BT54 6AR
20 February 2026
Glenbio Pharma UK Ltd
Statement of financial position
31 May 2025

|  |  | 2025 |  | 2024 |  |
|  |  | £ |  | £ |  |
Current assets |  |  | 100 |  | 100 |  |
Net current assets |  |  | 100 |  | 100 |  |
|  |  | _______ |  | _______ |  |
Total assets less current liabilities |  |  | 100 |  | 100 |  |
|  |  | _______ |  | _______ |  |
Net assets |  |  | 100 |  | 100 |  |
|  |  | _______ |  | _______ |  |
Capital and reserves |  |  | 100 |  | 100 |  |
|  |  | _______ |  | _______ |  |

Glenbio Pharma UK Ltd
Year ended 31 May 2025
The company did not trade during the year and has not made either a profit or loss.
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 20 February 2026 , and are signed on behalf of the board by:
Mr John McIntosh
Director
Company registration number: NI679621
The company is a private company limited by shares, registered in Northern Ireland.